March 20, 2018 7:43 AM ET

Diversified Consumer Services

Company Overview of The University Of Western Ontario

Company Overview

The University Of Western Ontario, offers professional courses for both graduate and under-graduate students. The University Of Western Ontario was founded in 1878 and is based in London, Ontario.

1151 Richmond Street

London, ON N6A 5B8


Founded in 1878



Key Executives for The University Of Western Ontario

President and Vice-Chancellor
Age: 74
Dean of Science Faculty
Associate Vice President of Communications and Public Affairs
Vice President of Research
Compensation as of Fiscal Year 2017.

The University Of Western Ontario Key Developments

The University Of Western Ontario Presents at British Pharmacological Meeting 2017, Dec-11-2017 through Dec-13-2017

The University Of Western Ontario Presents at British Pharmacological Meeting 2017, Dec-11-2017 through Dec-13-2017. Venue: Queen Elizabeth II Conference Centre, Broad Sanctuary, Westminster, London, United Kingdom. Presentation Date & Speakers: Dec-12-2017, Michael Rieder.

The University of Western Ontario Presents at 2017 World Congress on Industrial Biotechnology, Jul-23-2017

The University of Western Ontario Presents at 2017 World Congress on Industrial Biotechnology, Jul-23-2017 . Venue: Palais des congrès de Montréal, Montréal, Quebec, Canada. Speakers: Reyna Gomez-Flores, Doctorate Student.

Algae Dynamics Corp Announces Research Agreement with University of Western Ontario to Investigate the Use of Cannabis Derivatives

Algae Dynamics Corp. announced a research and product development agreement with Western University to perform research on cannabis oil and its constituents in the context of depression, post-traumatic stress disorder, anxiety and schizophrenia. This is the second of the recently announced research agreements with Canadian universities involving cannabis oil research. This announcement brings Algae Dynamics total university research contributions to $1.6 million for both programs. This research agreement will directly support this initiative and will focus on translational pharmaceutical research, with a specific focus on identifying how specific phytochemical compounds found in cannabis, including delta-9-tetrahydrocannbinol (THC), cannabidiol (CBD), cannabinoid-derived terpenoids and other potential phytochemical derivatives of cannabis may serve as novel pharmacological treatments for symptoms associated with depression, post-traumatic stress disorder, anxiety and schizophrenia. The Company's contribution to the four-year Sponsored Research Agreement, which commences April 1, 2017 and terminates March 30, 2021, is CAD 250,000 per year. The Company believes, from past experience, that it will be able to leverage the research expenditures with matching scientific grants pursuant to programs of various branches of government. The Company will be responsible for the filing of patents relating to this research and will own such patents if and when issued. The Company has agreed to make payments to the University upon filing of each patent, when each patent is issued, after first commercial sale and when gross sales reach CAD 1,000,000. There are no ongoing royalty payments, relating to the use of the patents. The work plan may be extended and modified to achieve best outcomes which may include delegating specific research areas of research work that require additional technologies to appropriate providers; and engaging research collaborators to extend the research into additional areas of benefit to the Company. The Company's core product development strategy has been the production of high volume specific algae species and extraction of Essential Fatty Acids (EFAs) which is the foundation of the endocannabinoid system (ECS). The ECS is a group of endogenous cannabinoid receptors located in the mammalian brain and throughout the central and peripheral nervous systems, consisting of neuromodulatory lipids and their receptors. The extracted algae Omega 3 oil with high concentrations of DHA is used as a health supplement product. In light of the potential synergies, the company has developed its strategy which is aimed at developing new products and formulations that combine the health benefits of algae and cannabis oils.

Similar Private Companies By Industry

Company Name Region
Aadmi Holdings Ltd. Americas
Abell Pest Control, Inc. Americas
Academy of Learning Americas
Access International Education Ltd. Americas
Acute Care Education, Inc. Americas

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
The Advertising Council, Inc. United States
Tax Management Inc United States
John F. Kennedy Center For The Performing Arts United States
NYC2012, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact The University Of Western Ontario, please visit Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at